Zymeworks Inc.
Industry: Life Sciences ・ $ZYME on Nasdaq
Insider Sale
+$854,782
-41.49%
Shares
Shares Volume: 57,291 Shares
Average Share Price: $14.92
INSIDER
Galbraith Kenneth
Chair & CEO (Director)
reported on Jan 6 2025
traded on Jan 6 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 80,803 |
| PURCHASES/SALES 1Y | 0 / 2 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $558,026.22 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 1 / 2 |
| PURCHASES/SALES 1Y | 3 / 5 |
| P/S VALUE RATIO | 16.969 |
| AVERAGE SALE VALUE | $290,886.23 |
| COMPANY PREVIOUS TRADES |